ANGIOTECH-BRANDED Sample Clauses

ANGIOTECH-BRANDED. COSTASIS PRODUCTS 16 5.1 Notice of Intent to Commercialize an Angiotech-Branded CoStasis Product(s) 16 5.2 Joint Committee Oversight 17 5.3 Promotion and Marketing 17 5.4 Booking of Product Sales 17 5.5 Promotional Materials 17 5.6 Branding of CoStasis Products by Angiotech 17 *** Certain information in this exhibit has been omitted and will be filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request under 17 C.F.R. Sections 200.80(b)(4) and 230.406. CONFIDENTIAL EXECUTION COPY TABLE OF CONTENTS (continued) Page
View Source

Related to ANGIOTECH-BRANDED

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Existing Products Except as set forth below, Contractor shall retain all rights, title and interest in Existing Products.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Products Products available under this Contract are limited to Software, including Software as a Service, products and related products as specified in Appendix C, Pricing Index. Vendor may incorporate changes to their product offering; however, any changes must be within the scope of products awarded based on the posting described in Section 1.B above. Vendor may not add a manufacturer’s product line which was not included in the Vendor’s response to the solicitation described in Section 1.B above.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.